Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression

Oncogene, Published online: 09 September 2019; doi:10.1038/s41388-019-0962-8Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression

Source: Oncogene - September 8, 2019 Category: Cancer & Oncology Authors: Hangchuan Shi Yin Sun Miao He Xiong Yang Michiaki Hamada Tsukasa Fukunaga Xiaoping Zhang Chawnshang Chang Source Type: research